The Board of Directors has considered and approved, inter-alia, the shifting of the Registered Office of the Company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Covidh Technologies Ltd, at its meeting on March 10, 2026, approved a major rebranding: changing the company name to 'iSERA Lifesciences Limited,' with MCA approval for the name reservation already obtained. The registered office is being shifted within Pune from Shukrawar Peth to Sadhu Vaswani Chowk, Camp, effective the same day. The board also recommended appointing two Executive Directors (Mr. Dhairyasheel Yadav with 18+ years in pharma/biotech, and Mr. Nandkumar Kadam with 20+ years in biopharma R&D) and two Non-Executive Directors (Mr. Pratap Deshmukh and Ms. Ritu Garad, both with life sciences/leadership backgrounds), all for 5-year terms subject to shareholder approval. An Extraordinary General Meeting has been scheduled for April 2, 2026, via video conferencing to seek member approvals for the name change and director appointments.
This announcement signals a full strategic pivot of the company from technology to the life sciences and biopharmaceutical space, backed by a leadership team with deep pharma/biotech credentials. Shareholders should watch the April 2 EGM closely, as the name change and board appointments will define the company's new direction; near-term stock sentiment may turn positive if the market views the pivot favorably, but execution risk in a new sector remains.